AKT1 and hepatocellular carcinoma: A recent report indicated that lapatinib mediates CIP2A inhibition, Akt inactivation, and apoptosis induction in HCC 1937, MDA-MB-468, and MDA-MB-231 triple-negative breast cancer cells [30].